Table 3 Comparison of antimicrobial resistance rate between ESBL and non-ESBL bacterial pathogens causing UTI among men with prostate enlargement at Muhimbili National Hospital, Dar es Salaam-TanzaniaÂ
Antimicrobial agent | Bacterial resistant patterns | p value | |
|---|---|---|---|
ESBL producers (N = 98), n (%) | Non-ESBL producers (N = 41), n (%) | ||
Amikacin | 38 (38.8) | 9 (22.0) | 0.008 |
Amoxicillin/clavulanic acid | 91 (92.9) | 35 (85.4) |  < 0.001 |
Ceftazidime | 90 (91.8) | 31 (75.6) |  < 0.001 |
Ceftriaxone | 89 (90.8) | 31 (63.3) |  < 0.001 |
Ciprofloxacin | 84 (85.7) | 39 (95.1) | 0.110 |
Gentamicin | 67 (68.4) | 25 (61.0) | 0.016 |
Meropenem | 23 (23.5) | 16 (39.0) | 0.297 |
Nitrofurantoin | 57 (58.2) | 28 (68.3) | 0.686 |
Trimethoprim/Sulfamethoxazole | 89 (90.8) | 39 (95.1) | 0.005 |